Metformin has been the first line drug treatment for type 2 diabetes for more than two decades and remains one of the most widely prescribed medicines globally. Its effectiveness, low cost and long safety record have made it a cornerstone of diabetes care. However, as...
Henry Li’s BioRoundup is a weekly analytical roundup that tracks where power, capital and science are actually moving in the global life-sciences ecosystem. Rather than simply reporting news headlines, Li curates developments from across deals, policy, industry...
Johnson & Johnson has discontinued development of an eczema treatment that was a central asset in a biotechnology acquisition valued at up to 1.25 billion US dollars, following a recent internal portfolio review. The decision highlights the ongoing scientific and...
Concerns are mounting that the United Kingdom’s official appraisal framework is systematically underestimating the economic and social value of investments in life sciences manufacturing. Industry bodies and independent analysts warn that the methods used to evaluate...
Henry Li’s BioRoundup is a weekly analytical roundup that tracks where power, capital and science are actually moving in the global life-sciences ecosystem. Rather than simply reporting news headlines, Li curates developments from across deals, policy, industry...
Manufacturing and supply chain resilience has moved to the forefront of strategic planning across the life sciences industry as advanced therapies place unprecedented strain on existing production models. Cell therapies, gene therapies, mRNA platforms and increasingly...
Why Sarcopenia Matters Sarcopenia, the age-related decline in skeletal muscle mass and strength, has become a growing concern in ageing populations. The condition contributes significantly to frailty, falls, fractures, disability and even mortality, placing an...
It is unusual for trade policy in the United States to have such a direct impact on the UK life sciences sector, but President Donald Trump’s proposed 100 per cent tariff on branded and patented pharmaceuticals could do just that. If enacted, the measure would impose...
The life sciences sector is undergoing a significant transformation as it embraces sustainable and green manufacturing practices. These initiatives aim to reduce environmental impact, enhance operational efficiency, and meet the growing demand for eco-friendly...
Genentech has carried out another round of workforce reductions, cutting 87 positions at its South San Francisco headquarters. The layoffs, filed last week and set to take effect on September 15, were disclosed in a California Worker Adjustment and Retraining...
Life with haemophilia can be challenging but advances in science are helping people with haemophilia to lead active and fulfilling lives. What is Haemophilia? Haemophilia is a family of rare genetic blood disorders caused by a clotting factor deficiency, which...
US pharmaceutical heavyweight Merck has decided to halt its planned £1 billion expansion in the UK, criticising the government for a lack of substantial investment in the life sciences sector. The company, which operates under the name MSD in Europe, announced it will...
The Food and Drug Administration commissioner, Marty Makary, has selected George Tidmarsh, a former biotech executive and Stanford-affiliated pediatrician, to lead the agency’s drug regulatory arm, according to a source familiar with the matter. The appointment of...